HLA-DRB1*14 is associated with lower odds of symptomatic SARS-CoV-2 infection in Mexican individuals
- DOI
- 10.3389/fimmu.2026.1907153
- Published
- 2026-09-01
- Container
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2026.1907153,
title = {HLA-DRB1*14 is associated with lower odds of symptomatic SARS-CoV-2 infection in Mexican individuals},
author = {Eric G. Hernández and Diego A. Daza-Mendoza and Enrique González-Rivas and Angélica Serrano-Vázquez and Horacio Pérez-Juárez and Alina Uribe-García and Gareth O. Rostro-Alonso and Patricia Morán-Silva and Liliana Rojas-Velázquez and Cecilia Ximénez García},
year = {2026},
journal = {Frontiers in Immunology},
doi = {10.3389/fimmu.2026.1907153},
url = {https://doi.org/10.3389/fimmu.2026.1907153}
}RIS
TY - JOUR TI - HLA-DRB1*14 is associated with lower odds of symptomatic SARS-CoV-2 infection in Mexican individuals AU - Eric G. Hernández AU - Diego A. Daza-Mendoza AU - Enrique González-Rivas AU - Angélica Serrano-Vázquez AU - Horacio Pérez-Juárez AU - Alina Uribe-García AU - Gareth O. Rostro-Alonso AU - Patricia Morán-Silva AU - Liliana Rojas-Velázquez AU - Cecilia Ximénez García PY - 2026 JO - Frontiers in Immunology DO - 10.3389/fimmu.2026.1907153 UR - https://doi.org/10.3389/fimmu.2026.1907153 ER -
APA
Hernández, E. G., Daza-Mendoza, D. A., González-Rivas, E., Serrano-Vázquez, A., Pérez-Juárez, H., Uribe-García, A., Rostro-Alonso, G. O., Morán-Silva, P., Rojas-Velázquez, L., & García, C. X. (2026). HLA-DRB1*14 is associated with lower odds of symptomatic SARS-CoV-2 infection in Mexican individuals. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1907153
Source records
- crossref · retrieved 2026-11-09T06:21:41.185Z